About Kyvor
Kyvor is a company based in Chennai (India) founded in 2016 by Abilesh Malli Gunasekar. Kyvor has raised $159.84 thousand across 1 funding round from investors including Anji Jain. Kyvor operates in a competitive market with competitors including GRAIL, Foundation Medicine, Color, Personalis and Novogene Corporation, among others.
- Headquarter Chennai, India
- Founders Abilesh Malli Gunasekar
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kyvor Genomics Private Limited
- Date of Incorporation 16 Aug, 2013
- Jurisdiction Madurai, Tamil Nadu, India
-
Annual Revenue
$83.07 K (USD)15.83as on Mar 31, 2021
-
Net Profit
-$29.76 K (USD)30.31as on Mar 31, 2021
-
EBITDA
$12.16 K (USD)431.96as on Mar 31, 2021
-
Total Equity Funding
$159.84 K (USD)
in 1 rounds
-
Latest Funding Round
$159.84 K (USD), Angel Round
Jul 27, 2017
-
Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Kyvor
Kyvor has successfully raised a total of $159.84K through 1 strategic funding round. The most recent funding activity was a Angel Round of $159.84 thousand completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kyvor
Kyvor has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Anji Jain.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AJ
Anji Jain |
-
|
Locked | Locked | Locked |
Investor details for Kyvor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kyvor
Investment portfolio details for Kyvor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kyvor
Detailed financials for Kyvor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kyvor Comparisons
Peer comparison for Kyvor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kyvor
Kyvor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Foundation Medicine, Color, Personalis and Novogene Corporation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Early cancer detection tests are developed using synthetic biomarkers.
|
Detailed competitors of Kyvor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kyvor
Complete news archive for Kyvor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kyvor
Kyvor was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Kyvor is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Abilesh Malli Gunasekar is the current CEO of Kyvor. They have also founded this company.
Kyvor is a funded company, having raised a total of $159.84K across 1 funding round to date.
Annual revenue of Kyvor is $83.07K as on Mar 31, 2021.
Kyvor was founded in 2016 in Chennai, India, as a genomics startup focused on precision oncology. Targeted therapy recommendations are offered based on patient genotypes through the CANLYTx product, which performs comprehensive genomic profiling for solid tumors using next-generation sequencing. Operations center on diagnostic services in the healthcare sector, supporting clinical decisions for cancer treatment.
Kyvor's top competitors include GRAIL, Foundation Medicine and MedGenome.
Kyvor has 1 investor. Key investors include Anji Jain.
The valuation of Kyvor is $1.61M as of Jul 2017.